Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Educ Prim Care ; 31(6): 365-370, 2020 11.
Artículo en Inglés | MEDLINE | ID: mdl-32862789

RESUMEN

Purpose: Nowadays chronicity is one of the most frequent aspects of care doctors have to deal with. Students need to know and learn clinical, relational, social and managerial elements of chronicity and changes that disease causes in patients, families and doctors themselves. Methods: Students are supervised by a family doctor, in taking care of 'their' patient and of his/her family. They are asked to keep an updated diary, participate in the periodical revision of the medical history and write an end-report. Two focus groups were conducted, adopting a constructive qualitative approach in order to analyse results. Results: The focus groups and the SWOT analysis show common themes such as innovative learning and multidisciplinary approach. Clinical evolution of the disease, mental and body changes and the diagnostic and therapeutic future planning were also revealed. Conclusions: The main goal of this innovation was understanding the importance of a continuous clinical relationship and of the role of the doctor as 'therapy itself'. The project was demonstrated to be able to teach the future physicians how to practice more empathetic medicine and to improve the skills needed in a complex relational environment including that of chronic disease.


Asunto(s)
Enfermedad Crónica , Continuidad de la Atención al Paciente , Educación de Pregrado en Medicina/métodos , Medicina Familiar y Comunitaria/educación , Medicina Familiar y Comunitaria/métodos , Grupos Focales , Humanos , Italia , Aprendizaje , Estudiantes de Medicina/psicología
2.
Acta Physiol (Oxf) ; 209(1): 34-44, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23746147

RESUMEN

AIMS: Glucagon-like peptide-1 (GLP-1) is an important modulator of insulin secretion by endocrine pancreas. In the present study, we investigated the effect of swim training on GLP-1 insulinotropic action in pancreatic islets from monosodium glutamate (MSG)-obese rats. METHODS: Obesity was induced by neonatal MSG administration. MSG-obese and control (CON) exercised rats swam for 30 min (3 times week(-1) ) for 10 weeks. Pancreatic islets were isolated by colagenase technique and incubated with low (5.6 mM) or high (16.7 mM) glucose concentrations in the presence or absence of GLP-1 (10 nM). In addition, GLP-1 gene expression in ileum was quantified in fasting and glucose conditions. RESULTS: Exercise reduced obesity and hyperinsulinemia in MSG-obese rats. Swim training also inhibited glucose-induced insulin secretion in islets from both groups. Islets from MSG-obese rats maintained GLP-1 insulinotropic response in low glucose concentration. In contrast, in the presence of high glucose concentration, GLP-1 insulinotropic action was absent in islets from MSG-obese rats. Islets from MSG-exercised rats showed reduced GLP-1 insulinotropic action in the presence of low glucose. However, in high glucose concentration swim training restored GLP-1 insulinotropic response in islets from MSG-obese rats. In all groups, glucose intake increased GLP-1 immunoreactivity and gene expression in ileum cells in relation to fasting conditions. Swim training reduced these parameters only in ileum cells from CON-exercised rats. Neither MSG treatment nor exercise affected GLP-1 expression in the ileum. CONCLUSIONS: Exercise avoids insulin hypersecretion restoring GLP-1's insulinotropic action in pancreatic islets from MSG-obese rats.


Asunto(s)
Péptido 1 Similar al Glucagón/metabolismo , Obesidad/metabolismo , Condicionamiento Físico Animal/fisiología , Glutamato de Sodio/metabolismo , Natación/fisiología , Animales , Animales Recién Nacidos , Péptido 1 Similar al Glucagón/farmacología , Glucosa/metabolismo , Insulina/metabolismo , Islotes Pancreáticos/efectos de los fármacos , Ratas Wistar
3.
Protein Eng Des Sel ; 23(2): 81-9, 2010 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-19955218

RESUMEN

Owing to its central role in DNA synthesis, human thymidylate synthase (hTS) is a well-established target for chemotherapeutic agents, such as fluoropyrimidines. The use of hTS inhibitors in cancer therapy is limited by their toxicity and the development of cellular drug resistance. Here, with the aim of shedding light on the structural role of the A-helix in fluoropyrimidine resistance, we have created a fluoropyrimidine-resistant mutant by making a single point mutation, Glu30Trp. We postulated that residue 30, which is located in the A-helix, close to but outside the enzyme active site, could have a long-range effect on inhibitor binding. The mutant shows 100 times lower specific activity with respect to the wild-type hTS and is resistant to the classical inhibitor, FdUMP, as shown by a 6-fold higher inhibition constant. Circular dichroism experiments show that the mutant is folded. The results of molecular modeling and simulation suggest that the Glu30Trp mutation gives rise to resistance by altering the hydrogen-bond network between residue 30 and the active site.


Asunto(s)
Mutación Puntual , Timidilato Sintasa/genética , Timidilato Sintasa/metabolismo , Dominio Catalítico , Dicroismo Circular , Fluorodesoxiuridilato/farmacología , Humanos , Enlace de Hidrógeno , Modelos Moleculares , Unión Proteica , Conformación Proteica , Timidilato Sintasa/antagonistas & inhibidores , Timidilato Sintasa/química
4.
Toxicol In Vitro ; 21(2): 240-8, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17118621

RESUMEN

Malignant melanoma is particularly resistant to conventional chemotherapy and radiotherapy. For this reason in the past years a huge variety of new compounds has been developed with potential chemotherapeutic activity which needs to be tested in vitro and in vivo. We investigated the in vitro action of three new experimental antifolate substances (MR7, MR21 and MR36) with a critical target for thymidylate synthase (TS), an essential enzyme for DNA synthesis. The response of two melanoma cell lines (SK-MEL-2 derived from malignant melanoma metastasis and SK-MEL-28 derived from primary malignant melanoma) was examined after treatment with these substances. The antifolate agents induced apoptosis in SK-MEL-2 and SK-MEL-28 cells as confirmed by the TUNEL technique and Comet Assay. Western-blot analysis showed a down-regulation of Bcl-2 protein level and PARP cleavage, otherwise p53 and Bax expressions were not modulated. Moreover, these antifolate-induced apoptosis was accompanied by both pro-caspase-9 and -8 activations. These results were supported by the use of the pan-caspases inhibitor Z-VAD-FMK that almost completely decreased the amount of apoptosis in both the melanoma cell lines treated with antifolate. In conclusion our results show that TS inhibitors are able to induce apoptosis through a caspase-mediated pathway, but without the involvement of the p53/Bax signalling.


Asunto(s)
Apoptosis/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Melanoma/tratamiento farmacológico , Timidilato Sintasa/antagonistas & inhibidores , Clorometilcetonas de Aminoácidos/farmacología , Caspasa 8/metabolismo , Caspasa 9/metabolismo , Línea Celular Tumoral , Fragmentación del ADN/efectos de los fármacos , Antagonistas del Ácido Fólico/farmacología , Humanos , Etiquetado Corte-Fin in Situ , Melanoma/patología , Poli(ADP-Ribosa) Polimerasas/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/antagonistas & inhibidores , Proteína p53 Supresora de Tumor/fisiología , Proteína X Asociada a bcl-2/fisiología
5.
Curr Med Chem ; 12(19): 2241-58, 2005.
Artículo en Inglés | MEDLINE | ID: mdl-16178783

RESUMEN

Recent methodologies applied to the drug discovery process, such as genomics and proteomics, have greatly implemented our basic understanding of drug action and are giving more input to medicinal chemists, in finding genuinely new targets and opportunities for the development of drugs with original mechanisms of action. In this paper, an example of the successful application of some new techniques to the target enzymes with the Thymidylate Synthase (TS) function is given. The improved knowledge of the complex mechanism of the biological pathways in which thymidylate synthase is involved represents a unique chance to find new mechanism-based inhibitors, aimed to treat not only cancerous diseases, but also infectious pathologies. Thymidylate synthase (TS or ThyA) has long been considered as one of the best-known drug targets in the anti-cancer area, after which old and new drugs, such as 5-fluoro uracil and the anti-folate ZD1694, have been introduced into chemotherapy to treat solid tumours. Only a few attempts have been made to find non-classical anti-folate inhibitors that are dissimilar to the folate co-factor, with the aim of finding unshared protein target domains on the enzyme structure, in order to specifically inhibit TS enzymes from pathogens. Only recently from omic studies, a new Thymidylate Synthase Complementing Protein (TSCP or ThyX) has been identified in a number of pathogens, showing a different structure with respect to human TS, thus opening new avenues to specific inhibitions. A depiction of the most recent progress in the study of Thymidylate Synthase enzymes is presented in the following sections.


Asunto(s)
Antineoplásicos/farmacología , Inhibidores Enzimáticos/farmacología , Antagonistas del Ácido Fólico/farmacología , Timidilato Sintasa/metabolismo , Antineoplásicos/uso terapéutico , Diseño de Fármacos , Inhibidores Enzimáticos/uso terapéutico , Fluorouracilo/farmacología , Fluorouracilo/uso terapéutico , Antagonistas del Ácido Fólico/uso terapéutico , Humanos , Datos de Secuencia Molecular , ARN Mensajero/genética , ARN Mensajero/metabolismo , Alineación de Secuencia , Relación Estructura-Actividad , Timidilato Sintasa/antagonistas & inhibidores , Timidilato Sintasa/química
6.
Gastroenterol Hepatol ; 27(8): 467-9, 2004 Oct.
Artículo en Español | MEDLINE | ID: mdl-15388051

RESUMEN

A case of malignant esophageal schwannoma is reported. A 54-year-old man consulted for a 1-year history of dysphagia. Investigations revealed a tumor of the distal esophagus, with involvement of the cardia, and were suspicious for metastatic mediastinal nodes. Ivor-Lewis esophagectomy with gastric-tube reconstruction was performed, with favorable outcome. Histological examination revealed esophageal sarcoma in a Barrett's esophagus. Periesophageal nodes had metastatic involvement. Immunohistochemical study was positive for S100 and vimentin and was negative for CD117, compatible with a diagnosis of esophageal schwannoma. We discuss this rare disease and its characteristics. This is the second reported case of malignant schwannoma with lymph node metastasis.


Asunto(s)
Neoplasias Esofágicas/patología , Neurilemoma/secundario , Neoplasias Esofágicas/diagnóstico por imagen , Neoplasias Esofágicas/cirugía , Esofagectomía , Gastroscopía , Humanos , Inmunohistoquímica , Ganglios Linfáticos/patología , Metástasis Linfática , Masculino , Persona de Mediana Edad , Neurilemoma/diagnóstico por imagen , Neurilemoma/cirugía , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
7.
Rev. chil. radiol ; 10(2): 50-52, 2004. ilus, tab
Artículo en Español | LILACS | ID: lil-387580

RESUMEN

El hígado graso es una entidad patológica que se caracteriza por acumulación de glóbulos de grasa dentro de los hepatocitos. Es una patología que en ultrasonido se diagnostica cada vez más, sin embargo es necesario usar algunos criterios para su diagnóstico. Nuestro objetivo fue estandarizar criterios ultrasonográficos, correlacionándolos con anatomía patológica, para diagnóstico de esteatosis y su cuantificación en grados de severidad (leve, moderado, severo). Este estudio mostró una concordancia moderada entre el ultrasonido y biopsia.


Asunto(s)
Adulto , Hígado Graso/patología , Hígado Graso , Ultrasonografía , Biopsia , Estudio de Evaluación
8.
Int J Oral Maxillofac Implants ; 11(6): 743-9, 1996.
Artículo en Inglés | MEDLINE | ID: mdl-8990635

RESUMEN

The purpose of this study was to investigate the impact of a modified surgical protocol and the survival of implants placed in the posterior maxilla. Forty-two implants were placed in the maxillary posterior area of 29 partially edentulous patients (17 men, 12 women; mean age 50 years; range 38 to 62 years) according to the modified surgical protocol. Twenty-nine of these implants had been placed into the maxillary tuberosity. All implants were checked radiologically every 12 months with a customized film holder. The restorations were fixed partial prostheses. Only 1 of the 42 implants was lost at stage 2 surgery. Results suggest that considerable benefits may be obtained by modifying a standard surgical protocol to maximize the results for a particular anatomic site.


Asunto(s)
Implantación Dental Endoósea/métodos , Implantes Dentales , Prótesis Dental de Soporte Implantado , Dentadura Parcial Fija , Maxilar/cirugía , Adulto , Pilares Dentales , Diseño de Prótesis Dental , Fracaso de la Restauración Dental , Femenino , Estudios de Seguimiento , Humanos , Arcada Parcialmente Edéntula/diagnóstico por imagen , Arcada Parcialmente Edéntula/patología , Arcada Parcialmente Edéntula/cirugía , Masculino , Maxilar/diagnóstico por imagen , Maxilar/patología , Persona de Mediana Edad , Oseointegración , Radiografía
9.
Eur J Pharmacol ; 241(1): 71-4, 1993 Sep 07.
Artículo en Inglés | MEDLINE | ID: mdl-8223928

RESUMEN

The inhibitory effect of one of the major proteins secreted by the rat seminal vesicles (SV-IV) on platelet-activating factor (PAF)-induced biological activities was investigated in vivo. SV-IV was found to prevent dose dependently both hypotension and acute bronchospasm caused by PAF administration in guinea-pigs. In addition, SV-IV inhibited both PAF- and ethanol-induced gastric mucosal injury in a dose-dependent manner.


Asunto(s)
Antiulcerosos/farmacología , Presión Sanguínea/efectos de los fármacos , Broncoconstricción/efectos de los fármacos , Factor de Activación Plaquetaria/antagonistas & inhibidores , Proteínas de Secreción Prostática , Proteínas/farmacología , Animales , Relación Dosis-Respuesta a Droga , Etanol , Cobayas , Masculino , Factor de Activación Plaquetaria/farmacología , Ratas , Ratas Wistar , Proteínas de Plasma Seminal , Úlcera Gástrica/inducido químicamente , Úlcera Gástrica/prevención & control
10.
Rev Med Chil ; 118(10): 1111-5, 1990 Oct.
Artículo en Español | MEDLINE | ID: mdl-2152628

RESUMEN

We report our experience with 19 patients with early gastric cancer in Valdivia, a southern province of Chile. All patients had symptoms and 15 had a preoperative biopsy. A mean of 39 days elapsed between biopsy and surgery. An emergency operation was performed in 3 patients. The mean lesion size was 10 cm2. An intramucous location was present in 9 patients and a submucous one in 10. Infiltration of the first lymph node barrier was observed in only 1 patient. A type P.1 resection was performed in 68% of patients, a type 2 resection in 11% and a type 3 in 5%. Recurrences were observed in 3 patients and 2 of them died. 5 year survival rate was 100% and 7 year survival was 68%.


Asunto(s)
Hospitales Generales , Neoplasias Gástricas/diagnóstico , Adulto , Anciano , Anciano de 80 o más Años , Biopsia , Chile/epidemiología , Femenino , Gastrectomía/estadística & datos numéricos , Hospitales Generales/estadística & datos numéricos , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/epidemiología , Recurrencia Local de Neoplasia/mortalidad , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/mortalidad , Estómago/patología , Neoplasias Gástricas/mortalidad , Neoplasias Gástricas/patología , Neoplasias Gástricas/cirugía , Análisis de Supervivencia
15.
Am J Surg ; 139(6): 832-7, 1980 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7386738

RESUMEN

Dose-response studies to tetragastrin were performed in patients with duodenal ulcer before and after highly selective vagotomy, hemigastrectomy and truncal vagotomy plus antrectomy. The calculated maximal response and the dose necessary to elicit 50 percent of that response (D50) were calculated by linear transformation of the results. Both highly selective vagotomy and hemigastrectomy were followed by a significant decrease in the stimulated acid output, characterized by a decrease in the calculated maximal response, but no change in the sensitivity of the parietal cells (D50) was observed. This indicates a noncompetitive reduction in the acid output. The calculated maximal response could not be restored to preoperative values by increasing the dose of stimulant. Truncal vagotomy plus antrectomy was followed by severe alteration in gastric physiology, and no linear transformation of the acid output could be made. This investigation shows that maximal acid output was obtained by the same dose of stimulant before and after all three operations studied. Therefore it is not necessary to increase the dose in postvagotomy acid studies.


Asunto(s)
Úlcera Duodenal/fisiopatología , Jugo Gástrico/metabolismo , Gastrinas/farmacología , Tetragastrina/farmacología , Adulto , Anciano , Relación Dosis-Respuesta a Droga , Úlcera Duodenal/cirugía , Femenino , Gastrectomía , Jugo Gástrico/efectos de los fármacos , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Antro Pilórico/cirugía , Distribución Aleatoria , Vagotomía/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA